- Home
- ZENV vs SRZN Comparison
ZENV vs SRZN Comparison
Compare ZENV & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- SRZN
- Stock Information
- Founded
- ZENV 2005
- SRZN 2015
- Country
- ZENV Brazil
- SRZN United States
- Employees
- ZENV N/A
- SRZN N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- ZENV Technology
- SRZN Health Care
- Exchange
- ZENV Nasdaq
- SRZN Nasdaq
- Market Cap
- ZENV 79.2M
- SRZN 72.8M
- IPO Year
- ZENV 2021
- SRZN N/A
- Fundamental
- Price
- ZENV $1.51
- SRZN $8.94
- Analyst Decision
- ZENV
- SRZN Strong Buy
- Analyst Count
- ZENV 0
- SRZN 2
- Target Price
- ZENV N/A
- SRZN $38.50
- AVG Volume (30 Days)
- ZENV 74.2K
- SRZN 21.5K
- Earning Date
- ZENV 07-02-2025
- SRZN 08-11-2025
- Dividend Yield
- ZENV N/A
- SRZN N/A
- EPS Growth
- ZENV N/A
- SRZN N/A
- EPS
- ZENV N/A
- SRZN N/A
- Revenue
- ZENV $155,164,999.00
- SRZN $11,638,000.00
- Revenue This Year
- ZENV $8.58
- SRZN N/A
- Revenue Next Year
- ZENV $8.83
- SRZN N/A
- P/E Ratio
- ZENV N/A
- SRZN N/A
- Revenue Growth
- ZENV 18.83
- SRZN N/A
- 52 Week Low
- ZENV $1.02
- SRZN $5.90
- 52 Week High
- ZENV $3.03
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- ZENV 51.14
- SRZN 50.24
- Support Level
- ZENV $1.43
- SRZN $8.00
- Resistance Level
- ZENV $1.90
- SRZN $9.88
- Average True Range (ATR)
- ZENV 0.16
- SRZN 0.82
- MACD
- ZENV 0.01
- SRZN -0.03
- Stochastic Oscillator
- ZENV 34.26
- SRZN 44.76
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).